NCT05433896View on ClinicalTrials.gov

Evaluating the Effects of Omeprazole on the Pharmacokinetics of XS004 (Dasatinib) Tablets in Healthy Adult Subjects Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

December 19, 2020

Study Completion Date

December 19, 2020

Conditions
PharmacokineticsDrug Interactions
Interventions
DRUG

Dasatinib ASD

XS004 Dasatinib Amorphous Solid Dispersion Film-Coated Tablet, 90 mg Test Formulation

DRUG

Omeprazole 40 MG

Omeprazole Delayed Release Capsules, USP 40 mg

Trial Locations (1)

56529-1342

AXIS Clinicals, Dilworth

Sponsors

Collaborators (1)

Axis Clinicals Limited
All Listed Sponsors
collaborator

Axis Clinicals Limited

INDUSTRY

lead

Xspray Pharma AB

INDUSTRY